Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (4): 370-376.doi: 10.12092/j.issn.1009-2501.2024.04.002

Previous Articles     Next Articles

Induced sputum testing in chronic airway disease and the prospects for its development

GAO Jiameng1.2, SHEN Yao2, XUE Liping1, CHEN Zhihong1   

  1. 1Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 2Department of Pulmonary and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China
  • Received:2023-09-28 Revised:2023-11-05 Online:2024-04-26 Published:2024-03-25

Abstract:

Induced sputum testing is a non-invasive test that reflects the nature and extent of airway inflammation and plays an important role in the diagnosis, treatment and prognosis of chronic airway diseases. This article outlines the development history of induced sputum technology, introduces the principle and operation of induced sputum technology, evaluates its safety, summarizes the three main test components, elaborates the role of this technology in various chronic airway diseases, such as reflecting the type of airway inflammation, predicting the efficacy of medication, and combining it with transcriptomics to study disease mechanisms, and briefly summarizes its innovations and makes a vision for the future.

Key words: induced sputum technique, chronic airway disease, application progress, prospects for development

CLC Number: